Women should seek prompt medical advice if they: Have been using retatrutide obtained from an unregulated or online source and experience any adverse symptoms Are pregnant, planning a pregnancy, or breastfeeding and have been offered or are considering retatrutide Have a history of thyroid cancer, pancreatitis, gallbladder disease, or eating disorders and are seeking weight management options Experience unexplained nausea, vomiting, severe abdominal pain, or changes in menstrual cycle while using any GLP-1-based therapy Red flag symptoms requiring urgent medical attention include: Severe or persistent abdominal pain (which may indicate pancreatitis or a gallbladder problem) call 999 or go to A&E if symptoms are severe or accompanied by systemic illness Signs of a serious allergic reaction such as facial swelling, difficulty breathing, or a widespread rash call 999 immediately Symptoms of hypoglycaemia (shakiness, sweating, confusion), particularly if taking other glucose-lowering medications Inability to keep fluids down, which may lead to dehydration and kidney problems seek same-day medical advice For women with obesity-related conditions such as PCOS, type 2 diabetes, or cardiovascular risk factors, a structured conversation with a GP or specialist is the safest starting point

Galhuber, M
Are you facing surgery for breast cancer, or considering surgery to decrease your risk of breast cancer
In short, as far as BPC 157s effectiveness is concerned, injections are superior to oral or nasal administration when it comes to sports injuries
In this article, we examine scientifically grounded information, results from laboratory studies, and the reasons why this myth continues to persist
The placebo-adjusted systolic BP change from baseline was 7.4 (95% CI, 10 to 4.7) mm Hg for the 5 mg tirzepatide dose, 10.6 (95% CI, 13.2 to 8) mm Hg for the 10 mg dose, and 8 (95% CI, 10.6 to 5.4) mm Hg for the 15 mg dose